Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
about
The evolving role of response-adapted PET imaging in Hodgkin lymphomaThe role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage diseaseFDG-PET/CT in lymphoma.Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationA pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.FDG-PET imaging in hematological malignanciesSurveillance imaging in pediatric Hodgkin Lymphoma.Current role of FDG PET/CT in lymphoma.The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).Rethinking clinical response and outcome assessment in a biologic age.18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?Interim response assessment for Hodgkin lymphoma: size matters.Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
P2860
Q26750993-4BCF0C4B-A1A4-416B-9D36-EBEC411A22C6Q26858893-9E53EE83-9805-49D3-906B-9E659AEF8F0DQ34408847-27A5BC65-8CE8-45B0-A060-4B8240303A73Q34663865-60A4D6B7-FBC7-4F5E-8214-6C6E7A96DBD3Q36816955-431DF97A-6210-49C0-A63F-D2260E4F11CFQ37144956-09CB49C2-0190-492B-8A8E-F98D61D41268Q37240835-322E46C9-2E22-4B6C-97E4-3E6783C15472Q37632114-7FD1B86E-CEA9-488A-98E5-2C45DB5EB449Q38119890-B09A6ABF-ED26-4FFD-B0A3-50ABC0B59CCEQ38187365-D7FE2F3B-D7D6-457B-BD67-2DFDFBBF0B94Q38365591-34239950-4254-433B-BB1F-9A083B595199Q38480777-E82AF79E-B2EF-4A64-8798-7D5C1C6046B3Q44750052-044C0A91-B702-4F18-9A9F-D1CA56482B11Q46579579-EA9614D3-2CDB-4026-8A07-9FFBD4FA90E1Q47305007-F0C03A52-409C-452F-8A5D-5CD392F9EDEBQ48194998-7182F8CE-AAE7-498E-B392-5B9921507CCBQ52929766-DA7CB917-313C-4660-9F18-19BA52F98152
P2860
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Interim [
@nl
Interim [(18)F]fluorodeoxygluc ...... response than each test alone?
@en
type
label
Interim [
@nl
Interim [(18)F]fluorodeoxygluc ...... response than each test alone?
@en
prefLabel
Interim [
@nl
Interim [(18)F]fluorodeoxygluc ...... response than each test alone?
@en
P2093
P2860
P1433
P1476
Interim [(18)F]fluorodeoxygluc ...... response than each test alone?
@en
P2093
Ann S LaCasce
Bruce D Cheson
Cancer Leukemia Group B
David J Straus
George P Canellos
Heiko Schöder
Jeffrey L Johnson
Lale Kostakoglu
Lawrence H Schwartz
Nancy L Bartlett
P2860
P304
P356
10.3109/10428194.2012.676173
P577
2012-08-28T00:00:00Z